EGP
Eilaf في حي مصر الجديدة | محلات الانترنت Eilaf حي مصر الجديدة (مصر)

Eilaf

+20 (2) 267-99-61
اتصالات

عنوان

مصر,  القاهرة ,  حي مصر الجديدة,  5 ش مصطفى رفعت - الدور 4 شقة 11 مساكن شيراتون

أرقام هاتف الشركة

الاتجاه
+20
حصلت .Allbiz على المعلومات عن طريق !Allbiz اشكرك على شراءك على
+20
حصلت .Allbiz على المعلومات عن طريق !Allbiz اشكرك على شراءك على

الإنترنت

الموقع:
حول

Eilaf

Eilaf is interested in considering later staged and licensed products. Eilaf intends to grow both organically and by acquisition. Our Business Innovation team focuses on the ‘search’ aspect of the Development strategy, including acquisition of companies and in-licensing of commercialized products. Our team is fully aware of the important aspect of creating long-term productive relationships with our patients/customers & the community we serve will encourage us to fulfill our planned mission. Eilaf is currently searching for more Biotechnology, Pharmaceutical & Medical technology companies who wish to operate in Egypt &/or MENA region. Eilaf is also, seeking the opportunity to go in to partnership with pharma companies which already exist in the market and would like to experience larger growth opportunity. For more information on Eilaf's partnering opportunities, please contact us @ innovation@eilaf.info. Eilaf Vision • To be a leading company in the development and commercialization of quality products/ devices in Pharma/medical market. • Persistently deliver new products to Markets. • In-Licensing and Marketing proprietary products/devices; and • Pursuing New Alliances. • Driving commercial excellent into the MENA region. • Exceeding patients/clients expectations. • Adding Branded generic products to our emerging market range, which are sourced externally and marketed under the Eilaf Pharma brand.
المنتجات والخدمات
Infasurf
توافر 
Infasurf is indicated for the PREVENTION of Respiratory Distress Syn-drome (RDS) in premature infants at high risk for RDS and for the TREATMENT "rescue" of newborn infants who develop RDS. Infasurf de-creases the incidence of RDS when used as prevention. When used either to prevent or treat RDS,...
المجموعة: أدوية
RhoGAM®
توافر 
RhoGAM® Brand was the first and is still the leading* Rho(D) immune globulin brand for the prevention of Rh hemolytic disease of the newborn (HDN). Prior to the introduction of RhoGAM® Brand in 1968, HDN was a major cause of infant mortality, responsible for an average of 10,000 deaths annually in...
المجموعة: أدوية
LiveInternet

وصف

جموعة كاملة من المنتجات والخدمات Eilaf. جميع المعلومات عن Eilaf في حي مصر الجديدة (مصر).